The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...
The U. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback